Does Rallies show 13F holders for STIM?

Yes. Rallies tracks hedge fund and 13F ownership data for STIM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is STIM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for STIM. It does not provide personalized investment advice.

STIM (Neuronetics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Neuronetics, Inc. Common Stock (STIM) is a publicly traded Healthcare sector company. As of May 21, 2026, STIM trades at $1.20 with a market cap of $82.11M and a P/E ratio of -0.85. STIM moved +0.00% today. Year to date, STIM is -15.60%; over the trailing twelve months it is -72.26%. Its 52-week range spans $0.52 to $5.92. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces STIM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns STIM stock?

Hedge funds tracked by Rallies that own STIM include Centerbook Partners and Bluecrest Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Neuronetics, Inc. Common Stock.

STIM Key Metrics

Key financial metrics for STIM
Metric	Value
Price	$1.20
Market Cap	$82.11M
P/E Ratio	-0.85
EPS	$-1.38
Dividend Yield	0.00%
52-Week High	$5.92
52-Week Low	$0.52
Volume	187.32K
Avg Volume	0
Revenue (TTM)	$74.89M
Net Income	$-43.73M
Gross Margin	72.32%

Top Hedge Funds Holding STIM

Centerbook Partners holds 106.65K shares of STIM, changed -67.30% as of Jun 30, 2025.
Bluecrest Capital holds 40.00K shares of STIM, changed +0.00% as of Dec 31, 2025.

Latest STIM News

Neuronetics Board Agrees Valuation Undervalues NeuroStar Platform, Seeks Engagement — Apr 7, 2026
Neuronetics Shares Jump 41% Following Q4 Revenue Surge to $41.8M — Feb 11, 2026

Recent STIM Insider Trades

Chernett Jorey bought 100.00K (~$117.00K) on May 19, 2026.
Chernett Jorey bought 475.00K (~$636.50K) on May 12, 2026.
Chernett Jorey bought 100.00K (~$151.00K) on Apr 21, 2026.

STIM Analyst Consensus

2 analysts cover STIM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.

Common questions about STIM

Who owns STIM stock?: Hedge funds tracked by Rallies that own STIM include Centerbook Partners and Bluecrest Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Neuronetics, Inc. Common Stock.
Does Rallies show 13F holders for STIM?: Yes. Rallies tracks hedge fund and 13F ownership data for STIM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is STIM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for STIM. It does not provide personalized investment advice.